Sneddon syndrome may present with neurological findings such as transient ischemic stroke, strokes, seizures and/or headaches. However, a purplish, spider web-like skin finding called livedo reticularis may accompany the skin and precede neurological findings. Sneddon syndrome often affects women. Since it is vasculopathy affecting small and medium vessels, other organ findings may accompany. We present a 44-year-old Sneddon syndrome patient with monoparesis in her left lower extremity, livedo reticularis on her back and legs, and hypertension.

Download full-text PDF

Source
http://dx.doi.org/10.3897/folmed.66.e106231DOI Listing

Publication Analysis

Top Keywords

sneddon syndrome
16
neurological findings
8
livedo reticularis
8
antiphospholipid antibody
4
antibody positive
4
sneddon
4
positive sneddon
4
syndrome
4
syndrome case
4
case report
4

Similar Publications

Comprehensive insights of Sneddon syndrome: A clinical perspective.

J Cent Nerv Syst Dis

December 2024

Faculty of Medicine, The Hashemite University, Zarqa, Jordan.

Background: Sneddon's syndrome is a rare thrombotic vasculopathy characterized by the coexistence of both cerebrovascular events and livedo reticularis.

Objective: This review aims to raise awareness among physicians by discussing the whole clinical spectrum of the disease. Typically, Sneddon syndrome presents in middle-aged women with a cerebrovascular accident and a preexisting skin rash, which is livedo reticularis.

View Article and Find Full Text PDF

Sneddon's Syndrome with Underlying Protein S Deficiency and Decreased Protein C Activity.

Skinmed

August 2024

Department of Dermatology, Venereology & Leprosy, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Dehradun, Uttarakhand, India.

View Article and Find Full Text PDF

Background: Sneddon syndrome is an occlusive vasculopathy that presents clinically with generalized livedo racemosa on the skin and transient ischemic attacks, strokes, and cognitive or motor deficits in the central nervous system. Antiplatelet or anticoagulant therapy is recommended. Due to the limited therapeutic efficacy and the resulting serious complications, we propose combination therapy with additional infusion cycles of alprostadil and captopril and report initial long-term results.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!